News - Business (571 items)
(All links open in new tab)
| Sep 14, 2026 |
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts EDMONTON, AB, Sept. 14, 2026 /CNW/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today responded to the application by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) to halt Aurora's at-the-market ("ATM") program. Aurora believes Curaleaf's filing is simply the latest attempt to distract shareholders from the fundamental issue before them: Curaleaf's hostile bid significantly undervalues Aurora and seeks to acquire Aurora's cash, unique EU-GMP assets, global growth platform and future upside at a discount. |
|---|---|
| Sep 14, 2026 |
Indigenous cannabis shop owners fight Ottawa closures
The email came one day in May, 2025. Bryan Brant’s landlord said the police had contacted him about his cannabis dispensary and that Brant was being evicted. He had 48 hours to vacate his shop — Native Cannabis Depot — on Bank Street. Brant, as an Indigenous businessperson, claimed he had rights to open and run such an unlicensed shop. But the closure became just one of several in Ottawa that he and another Indigenous owner have been fighting. |
| Sep 14, 2026 |
Curaleaf asks Alberta regulator to halt Aurora's share issuances while its offer stands
Curaleaf has filed an application with the Alberta Securities Commission seeking to stop Aurora Cannabis from issuing shares under its at-the-market program for as long as Curaleaf's offer for the company remains outstanding. The application asks the commission to halt further issuances immediately and to protect the ability of Aurora shareholders to consider and respond to the offer, and Curaleaf has requested an expedited hearing. It follows Curaleaf's formal offer for all issued and outstanding Aurora shares, commenced on 19 August at 0.3463 Curaleaf subordinate voting shares plus US$0.75 in cash per Aurora share, which the company values at approximately US$4.00, and Aurora's rejection of it. |
| Sep 14, 2026 |
Cannabis: do workplaces have a problem with ‘drug thinking’?
A laboratory can answer the wrong question perfectly. An employee provides a sample. The result is positive for cannabis. The analysis may be technically sound, the chain of custody secure and the paperwork satisfyingly complete. But what, exactly, has the test shown? That has become harder to answer since 2018, when certain cannabis-based products for medicinal use were moved into Schedule 2 of the Misuse of Drugs Regulations, creating a lawful route to prescription. Recreational cannabis did not become legal. Yet cannabis can now sit, depending on context, on both sides of a workplace ‘drug’ policy: prescribed medicine and illicit drug. The Care Quality Commission reported a 130% rise in private prescription items for unlicensed cannabis-based medicinal products between 2022-23 and 2023-24. Those are prescription items, not patients, but the rise makes medical cannabis increasingly difficult for employers to regard as marginal. |
| Sep 11, 2026 |
What Curaleaf’s hostile takeover bid for Aurora Cannabis is really about
First, this is not a $4 cash offer. Aurora shareholders would receive $0.75 in cash and 0.3463 Curaleaf subordinate voting shares for each Aurora share. When Curaleaf announced the bid, that package was worth approximately $4. But its value changes with Curaleaf’s stock price, which during trading Thursday afternoon was hovering around $10.09 per share on over-the-counter markets. Despite announcing intentions to uplist to a major exchange in May, Curaleaf remains listed on OTC. If Curaleaf’s stock falls, Aurora shareholders receive less. If Curaleaf’s stock rises far enough, the exchange ratio is reduced so that the total consideration does not exceed $5 per share. Aurora shareholders are exposed to the decline, but their upside stops at $5. The cash portion deserves a closer look. |
| Sep 10, 2026 |
Avicanna Launches New Integrated Health Program to Expand Medical Cannabis in Clinical Settings
Medical cannabis company Avicanna Inc. has launched a new program to support healthcare organizations looking to incorporate medical cannabis into their existing models of care. The Toronto-based company is expanding its MyMedi.ca platform as part of its new Integrated Health Program, designed to integrate medical cannabis care and patient support into Canadian healthcare institutions and clinical networks. The new program builds on Avicanna’s existing MyMedi.ca platform, a medical cannabis care infrastructure to better serve medical cannabis patients’ needs. |
| Sep 9, 2026 |
CT cannabis company continues hostile takeover fight with Canadian rival Stamford-based cannabis giant Curaleaf Holdings has fired the latest salvo in its hostile takeover fight with Canadian company Aurora Cannabis. Curaleaf announced in August that it intended to acquire Aurora Cannabis for $4 per share, saying the proposal represented a 45% premium to Aurora’s 30-day average share price. The company said at the time it had initially approached Aurora privately in June and followed up in July after the Canadian company declined to engage. |
| Sep 9, 2026 |
Can South Africa challenge Canada for global cannabis export dominance?
In a challenge to licensed cannabis producers in Canada, long the global export leader, a growing share of cannabis exports is coming from companies in South Africa. Firms in South Africa enjoy lower production costs, but they’re also meeting European Union standards for pest control as well as EU-GMP requirements. With European markets increasingly interested in GMP-compliant product that’s also non-irradiated, South African cannabis producers are mounting a direct threat to Canadian LPs, operators told MJBizDaily. “South Africa is quickly becoming a serious exporter to Germany,” said Johan Slabber, the CEO of Nexus Pharma, which bills itself as South Africa’s first vertically integrated THC company. |
| Sep 4, 2026 |
Aurora Cannabis Falls Under Pressure as Sentiment Weakens and Strategic Uncertainty Builds
Aurora Cannabis Inc. (TSX: ACB) is a Canada-based global medical cannabis company focused on the production, distribution and sale of cannabis products, with an emphasis on medical markets and international expansion. Its Business model has increasingly shifted toward higher-value medical cannabis markets, supported by international distribution capabilities and a growing presence across regulated jurisdictions. Aurora has also pursued acquisitions and capacity expansion intended to strengthen its position in international medical cannabis. |
| Sep 3, 2026 |
Canada’s Cannabis Vape Boom Has a Trash Problem
Cannabis vapes, including both single-use and 510 cartridges, comprise almost 20% of total cannabis sales every year across Canada. This has resulted in upwards of 3,550 tonnes of waste over the past four years, and that number is growing at a significant rate each year, creating a significant environmental footprint. Canada’s legal cannabis industry has come a long way since recreational cannabis was legalized in October 2018. Consumers now have an enormous selection of products available through thousands of legal retailers across the country. |
| Sep 3, 2026 |
Curaleaf responds to Aurora's rejection by citing its share sales at US$3.09
Curaleaf has answered Aurora's rejection of its bid by pointing at the prices Aurora's own board sold shares at. Aurora's board told shareholders to take no action and to withdraw any shares already tendered. Curaleaf responded on 2 September, and its case turns on the at-the-market equity programs Aurora has used to fund the debt-free balance sheet it put at the center of its defense. |
| Sep 3, 2026 |
Cannabis in Quebec: The 21-Year-Old Age Requirement in the Spotlight La décision du Québec de fixer l’âge légal pour la consommation de cannabis à 21 ans fait une nouvelle fois l’objet d’un examen minutieux, les experts en toxicomanie, les représentants de la santé publique et les acteurs du secteur s’interrogeant sur la capacité de cette restriction à atteindre les objectifs de santé publique visés. Plus de 15 000 personnes âgées de moins de 21 ans se sont vu refuser l’accès aux magasins de la Société québécoise du cannabis (SQDC) l’année dernière, selon les chiffres cités par le détaillant provincial de cannabis. |
| Sep 3, 2026 |
Cannabis at work: key lessons for employers
As prescriptions for medical cannabis become more common, employers are facing a difficult shift in workplace drugs management. For years, many organisations have treated a positive cannabis test as a straightforward disciplinary issue. That approach is increasingly risky. Where cannabis has been lawfully prescribed, the key question is not simply whether cannabis is present, but whether the employee is fit for work, whether their condition may be a disability, and whether the employer’s response is reasonable and evidence-based. |
| Sep 3, 2026 |
Cannabis consumers are no longer stoner stereotypes. Not all brands are marketing accordingly
When it comes to marijuana, millennials may be the last generation of Americans to grow up when Amsterdam still had a whiff of the mystical. For those who were cannabis-curious in the ‘90s and early-aughts, Amsterdam represented an impossible dreamland where one could simply walk into The Weed Store and legally purchase what then amounted to contraband stateside. |
| Sep 2, 2026 |
Aurora Cannabis urges shareholders to reject hostile takeover offer by Curaleaf
Aurora Cannabis Inc. is urging its shareholders to reject a hostile takeover bid by Curaleaf Holdings, Inc. The company says the unsolicited bid by Curaleaf undervalues Aurora and is not in the best interests of shareholders. Aurora says it is debt free and has about C$149 million in cash, while Curaleaf has over C$1 billion in debt and would gain control over its cash without paying fairly. |
| Sep 1, 2026 |
Cannabis Jobs Update – September 2026
Canada’s cannabis industry is hiring. In our September 2026 job roundup, we’ve highlighted open roles in retail, cultivation, processing, brand management, and operational support, as well as a few international opportunities. Whether you are an industry veteran looking for your next career move or a newcomer eager to enter the space, there are options available across every stage of the supply chain. Explore the listings below to find your fit. |
| Aug 31, 2026 |
BC, Ontario Lead in Cannabis Licensing in 2026, Revocations Surpass New Licences
There have been 45 new cannabis production licences issued in Canada in the first eight months of 2026. As of the end of August, there are 900 federal cannabis licences. More than seven in 10 of these new licences were Micros (32), 24% were Standard (11), and one each was a Nursery and a Medical Sales-Only licence. Most new Micros (18 of 32) received both a Micro cultivation and a Micro Processing licence. British Columbia was home to the most new licences, with 18 (15 Micro, two Standard, one MSO). Ontario followed this with 12 (six Micro, six Standard), and Quebec with eight.* |
| Aug 29, 2026 |
The Industry Bet Against Bud. Flower Smokers Never Left.
The cannabis industry spent years predicting flower’s decline. Grown Rogue CEO and co-founder Obie Strickler argues that the prediction said more about industry executives than it did about consumers. |
| Aug 28, 2026 |
Diversity is not the same as equity in US cannabis industry
(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.) The first time I understood cannabis enforcement, I was with five friends on the side of a road while police searched our car. Only one of us was white. He had smoked a blunt. An officer said he smelled cannabis, and that was reason enough to detain all six of us and search the vehicle. The officer didn’t know who had smoked or what lives we would go on to lead. In that moment, a smell turned a group of young men into a police matter. new framework ctas (2) My white friend later became an exceptional legal cannabis grower, but prohibition affected him by criminalizing the plant around which he developed expertise. I entered government and worked on cannabis regulation, social equity funding and business development. Both stories belong in the legal cannabis industry. But that encounter taught me that the same law can touch several people without leaving the same scars. That difference is what equity is supposed to measure. Are diversity and equity synonyms? Diversity asks who is present. Inclusion asks who is permitted to participate. Equity asks who was harmed, what was taken from them and whether resources, authority and opportunity are being directed toward repairing that injury. A cannabis company can employ people of different races and genders while ownership, investment and executive control remain concentrated among people with the greatest access to capital. |
| Aug 28, 2026 |
The Future of Cannabis Tourism Starts on the Farm
Cannabis Wine Tours founder Charles Kimball argues that farmer-hosted experiences can connect visitors with the land while giving small Northern California growers another way to be seen and supported. |